Immunotherapy in cervical cancer: historic breakthroughs beating checkpoints

Richard T. Penson


Who benefits from immunotherapy? What constitutes a breakthrough? Where do the blockbuster pharmaceutical come from? When are clinical and scientific dreams realized? Why does getting a drug to market require such a huge, long and costly investment? How do we pick the winners?